Abstract 2270: RAGE-ligand signaling drives breast cancer invasion and metastasis
Taekyoung Kwak(Seoul National University), Barry I. Hudson(Columbia University Irving Medical Center), Joyce M. Slingerland(University of Miami), Ayse Burcu Ergonul(University of Miami), Katherine Drews‐Elger(University of Miami), Dekuang Zhao(University of Miami), Alexander Besser(University of Miami), Marc E. Lippman(Georgetown University)
Cited by 0
Related Papers
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
|Cell|2014|798
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Breast Cancer
|New England Journal of Medicine|1992|701
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
|Journal of Clinical Investigation|2011|417
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
|Journal of Clinical Investigation|2008|363